metformin and ex 527

metformin has been researched along with ex 527 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ	1
Apetoh, L; Berger, H; Boidot, R; Chalons, P; Delmas, D; Derangère, V; Euvrard, R; Ghiringhelli, F; Humblin, E; Ladoire, S; Limagne, E; Rébé, C; Thibaudin, M; Végan, F	1

Other Studies

2 other study(ies) available for metformin and ex 527

Article	Year
Identification of potent Yes1 kinase inhibitors using a library screening approach. Bioorganic & medicinal chemistry letters, 2013, Aug-01, Volume: 23, Issue:15 Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship	2013
Sirtuin-1 Activation Controls Tumor Growth by Impeding Th17 Differentiation via STAT3 Deacetylation. Cell reports, 2017, 04-25, Volume: 19, Issue:4 Topics: Acetylation; Animals; Carbazoles; CD4-Positive T-Lymphocytes; Cell Differentiation; Cell Line, Tumor; Heterocyclic Compounds, 4 or More Rings; Humans; Melanoma, Experimental; Metformin; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Nuclear Receptor Subfamily 1, Group F, Member 3; Sirtuin 1; STAT3 Transcription Factor; Th17 Cells; Transplantation, Heterologous	2017

Article

Year

Identification of potent Yes1 kinase inhibitors using a library screening approach.

Bioorganic & medicinal chemistry letters, 2013, Aug-01, Volume: 23, Issue:15

Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship

2013

Sirtuin-1 Activation Controls Tumor Growth by Impeding Th17 Differentiation via STAT3 Deacetylation.

Cell reports, 2017, 04-25, Volume: 19, Issue:4

Topics: Acetylation; Animals; Carbazoles; CD4-Positive T-Lymphocytes; Cell Differentiation; Cell Line, Tumor; Heterocyclic Compounds, 4 or More Rings; Humans; Melanoma, Experimental; Metformin; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Nuclear Receptor Subfamily 1, Group F, Member 3; Sirtuin 1; STAT3 Transcription Factor; Th17 Cells; Transplantation, Heterologous

2017